A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients

Infection

Volumn 24, Issue 6, 1996, Pages 426-432

  Abele Horn, M ^a   Kopp, A ^b   Sternberg, U ^b   Ohly, A ^b   Dauber, A ^b   Russwurm, W ^b   Buchinger W ^b   Nagengast, O ^b   Emmerling, P ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Klinikum Schwabing   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE;

ADULT; AGED; ARTICLE; CANDIDIASIS; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HYPOKALEMIA; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PERITONITIS; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; RIGOR; SEPSIS;

ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CANDIDIASIS; CROSS INFECTION; DRUG THERAPY, COMBINATION; FEMALE; FLUCONAZOLE; FLUCYTOSINE; FUNGEMIA; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0030451264     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01713042     Document Type: Article

References (20)

1. Edward, J. E.: Invasive Candida infections. Evolution of a fungal pathogen. N. Engl. J. Med. 324 (1991) 1059-1062.
2. Fraser, V. J., Jones, M., Dunkel, J., Storfer, S., Medoff, G., Dunagan, W. C.: Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin. Infect. Dis. 15 (1992) 414-421.
3. Harvey, R. L., Myers, J. P.: Nosocomial fungemia in a large community teaching hospital. Arch. Intern. Med. 147 (1987) 2117-2120.
4. Komshian, S. V., Uwaydah, A. K., Sobel, J. D., Crane, L. R.: Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev. Infect. Dis. 11 (1989) 379-390.
5. Wey, S. B., Mori, M., Pfaller, M. A., Woolson, R. F., Wenzel, R. P.: Hospital acquired candidemia: the attributable mortality and excess length of stay. Arch. Intern. Med. 148 (1988) 2642-2645.
6. Johnson, D., Thompson, T., Green, T., Ferrieri, P.: Systemic candidiasis in very low birth weight infants (<1500 g). Pediatrics 73 (1984) 138-143.
7. Graninger, W., Presterl, E., Schneeweiss, B., Teleky, B., Georgopoulos, A.: Treatment of Candida albicans fungemia with fluconazole. J. Infect. 26 (1992) 133-146.
8. Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., Levenstein, M. J., Webb, C. D.: A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N. Engl. J. Med. 331 (1994) 1325-1330.
9. Van't Wout, J. W., Mattie, H., Van Furth, R.: A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections. J. Antimicrob. Chemother. 21 (1988) 665-672.
10. Isalska, B. J., Stanbridge, T. N.: Fluconazole in treatment of candidal prosthetic valve endocarditis. Br. Med. J. 297 (1988) 178-179.
11. Levine, J., Bernard, D. B., Idelson, B. A., Farnham, H., Saunders, C., Sugar, A. M.: Fungal peritonitis complicating continuous ambulatory peritonitis: successful treatment with fluconazole, a new orally active antifungal agent. Am. J. Med. 86 (1989) 825-827.
12. Ikemoto, H.: A clinical study of fluconazole in the treatment of deep mycoses. Diagn. Microbiol. Infect. Dis. 12 (1989) S239-S247.
13. Knaus, W. A., Draper, E., Douglas, P., Wagner, D. P., Zimmermann, J. E.: APACHE II: a severity of disease classification system. Crit. Care. Med. 13 (1985) 818-829.
14. Gutierrez, J., Maroto, C., Piedrola, G., Martin, E., Perez, J. A.: Circulating Candida antigens and antibodies: useful markers of candidemia. J. Clin Microbiol. 31 (1993) 2550-2552.
15. Polak, A.: Combination therapy for systemic mycosis. Infection 17 (1989) 203-209.
16. Just-Nübling, G., Stille, W.: Therapie von Systemmykosen bei Abwehrschwache. Immun. Infekt. 19 (1991) 116-120.
17. British Society for Antimicrobial Chemotherapy Working Party: Management of deep Candida infection in surgical and intensive care unit patients. Int. Care Med. 20 (1994) 522-528.
18. Gold, J. W. M.: Infections due to fungi, actinomyces, and nocardia. In: Reese, R. E., Betts, R. F. (eds.): A practical approach to infectious diseases, 3rd ed., Little, Brown and Company, Boston, Toronto, London 1991, pp. 512-565.
19. Kujath, P., Lerch, K., Kochendörfer, P., Boos, J.: Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses. Infection 21 (1993) 376-382.
20. Sobel, J. D.: Candida infections in the intensive care unit. Crit. Care Clinics 2 (1988) 325-344.